We determined the incidence, risk factors, and outcomes of bloodstream infections (BSI) subsequent to Clostridium difficile infection (CDI). We performed a retrospective study of all patients with definite diagnosis of CDI admitted from January 2014 to December 2014 in two large hospitals in Rome. C lostridium difficile infection (CDI) is an emerging infection, usually occurring after exposure to broad-spectrum antibiotics (1-3). This infection can be mild and self-limiting but might progress to severe disease with ileus, toxic megacolon, and eventually, death. The incidence, severity, and acquisition of infection of people formerly classified as being at low risk seem to be increasing, and a hypervirulent, fluoroquinolone-resistant C. difficile strain, named NAP1/BI/027, is associated with severe symptoms, high recurrence rates, and poor outcomes (4-6).The alterations occurring in the intestinal flora, which is recognized as a microbiome, may promote the translocation of pathogens in the blood and the development of nosocomial bloodstream infections (BSIs) (7). Recently, we reported our experience of studying candidemia subsequent to severe CDI (8-10), and we observed an association between Candida species BSI and CDI, especially if caused by ribotype 027 strains. We reported a case of severe community-onset health care-associated CDI complicated by carbapenemase-producing Klebsiella pneumoniae BSI (11). Thus, it was hypothesized that antibiotic therapy and/or other clinical characteristics related to CDI (i.e., severity, recurrence, disease caused by a highly virulent strain, etc.) contribute to alterations of the colon indigenous microbiota and eventually predispose patients to .The aim of our study was to analyze the clinical findings for patients with CDI and primary nosocomial BSI to determine the risk factors and outcomes associated with these infections.(This work was presented as an oral communication during the 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 17 to 21 September 2015 [15].)
MATERIALS AND METHODSStudy design and study patients. This was a retrospective study of patients who were admitted from January 2014 to December 2014 to two large hospitals in Rome: Policlinico Umberto I-Sapienza University Hospital (1,200 beds and 49,000 admissions/year in 2014) and the San Giovanni-Addolorata Hospital (700 beds and 30,000 admissions/year in 2014). All adults (aged Ͼ18 years) with a documented CDI initially were included in the study. Patients for whom we could not obtain medical records were excluded from the final analysis. The ethics committee of the Policlinico Umberto I approved the study.Data were extracted from the medical records of patients and from hospital computerized databases or clinical charts according to a prepared questionnaire. The following data were reviewed: demographics, clinical and laboratory findings, comorbidity conditions (like diabetes mellitus, cardiovascular disease, pulmonary disease, renal disease, hepatic disease, central nervous...